Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1625 of 1863 entries
View as:

A New Psychotherapy Intervention for Older Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04452825 Org: User:
Start: 02/01/21 End: 06/30/25 Due: 06/30/26

PET Imaging With 89Zr-DFO-Trastuzumab in Esophagogastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02023996 Org: User:
Start: 12/31/13 End: 06/27/23 Due: 06/27/24

PET and MRI Imaging of Brain Tumors Using [18F]PARPi

Phase: N/A Priority: Normal
NCT ID: NCT04173104 Org: User:
Start: 11/01/19 End: 11/30/25 Due: 11/30/26

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04161781 Org: User:
Start: 11/12/19 End: 03/06/24 Due: 03/06/25

A Study of the Use of Text Message Reminders to Take Palbociclib

Phase: N/A Priority: Normal
NCT ID: NCT04216576 Org: User:
Start: 12/27/19 End: 12/27/25 Due: 12/27/26

Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT00461084 Org: User:
Start: 04/30/07 End: 09/30/14 Due: 09/30/15

A Study of Meaning-Centered Psychotherapy for Caregivers to People With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06307535 Org: User:
Start: 03/13/24 End: 03/01/29 Due: 03/01/30

LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03684980 Org: User:
Start: 11/14/18 End: 11/30/26 Due: 11/30/27

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

Phase: N/A Priority: Normal
NCT ID: NCT06773208 Org: User:
Start: 01/07/25 End: 01/31/27 Due: 01/31/28

Study of Recovery of Strength After Surgery Comparing Two Different Medications for Reversal of Muscle Relaxant

Phase: N/A Priority: Normal
NCT ID: NCT03116997 Org: User:
Start: 04/07/17 End: 03/03/22 Due: 03/03/23

Stopping Maintenance Therapy in People With Multiple Myeloma in MRD-Negative Remission

Phase: N/A Priority: Normal
NCT ID: NCT04221178 Org: User:
Start: 01/03/20 End: 01/03/26 Due: 01/03/27

Ulixertinib in People With Histiocytic Neoplasms

Phase: N/A Priority: Normal
NCT ID: NCT06411821 Org: User:
Start: 05/07/24 End: 05/31/27 Due: 05/31/28

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Phase: N/A Priority: Normal
NCT ID: NCT05093335 Org: User:
Start: 10/01/21 End: 10/31/26 Due: 10/31/27

Lenalidomide Intensification in Patients With Serologic/Asymptomatic Progression of Multiple Myeloma While on Lenalidomide Maintenance

Phase: N/A Priority: Normal
NCT ID: NCT01463670 Org: User:
Start: 10/28/11 End: 03/19/21 Due: 03/19/22

A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05556798 Org: User:
Start: 10/04/22 End: 10/31/26 Due: 10/31/27

A Study of Pembrolizumab and Radiation Therapy in People With Mesothelioma

Phase: N/A Priority: Normal
NCT ID: NCT04897022 Org: User:
Start: 08/10/21 End: 08/31/26 Due: 08/31/27

A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant

Phase: N/A Priority: Normal
NCT ID: NCT05540340 Org: User:
Start: 09/09/22 End: 09/30/25 Due: 09/30/26

A Study to Assess Thymic Function Using PET/CT and MRI

Phase: N/A Priority: Normal
NCT ID: NCT02909075 Org: User:
Start: 08/31/16 End: 01/31/20 Due: 01/31/21

A Formative Evaluation For Improving Breast Cancer Hormone Receptor Testing in Tanzania

Phase: N/A Priority: Normal
NCT ID: NCT05438511 Org: User:
Start: 04/13/23 End: 04/30/26 Due: 04/30/27

A Study of AZD1390 and Stereotactic Body Radiotherapy (SBRT) for People With Metastatic Solid Tumor Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05678010 Org: User:
Start: 05/17/23 End: 05/17/28 Due: 05/17/29

Pre-operative Chemotherapy Plus Bevacizumab With Early Salvage Therapy Based on PET Assessment of Response in Patients With Locally Advanced But Resectable Gastric and GEJ Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00737438 Org: User:
Start: 08/31/08 End: 02/28/15 Due: 02/28/16

High Dose Therapy and Autologous Stem Cell Transplantation Followed by Infusion of Chimeric Antigen Receptor (CAR) Modified T-Cells Directed Against CD19+ B-Cells for Relapsed and Refractory Aggressive B Cell Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT01840566 Org: User:
Start: 04/30/13 End: 04/30/26 Due: 04/30/27

Study of CAR-T Therapy in Older Patients

Phase: N/A Priority: Normal
NCT ID: NCT04300998 Org: User:
Start: 03/04/20 End: 03/04/26 Due: 03/04/27

International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Phase: N/A Priority: Normal
NCT ID: NCT01504152 Org: User:
Start: 12/31/11 End: 07/31/13 Due: 07/31/14

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Phase: N/A Priority: Normal
NCT ID: NCT00003357 Org: User:
Start: 01/31/98 End: 11/30/01 Due: 11/30/02